1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Designing drugs against Hsp90 for cancer therapy
    Book Section

    Ochiana, S. O.; Taldone, T.; Chiosis, G.
    In Houry, W. A. (Eds.) The Molecular Chaperones Interaction Networks in Protein Folding and Degradation (2014)

    Fulltext@MSK | Save
  • Role of molecular imaging in the era of personalized medicine: A review
    Book Section

    Sala, E.; Vargas, H. A.; Donati, O. F.; Weber, W. A.; Hricak, H.
    In Luna, A.; Vilanova, J. C.; da Cruz, L. C. H. Jr; Rossi, S. E. (Eds.) Functional Imaging in Oncology: Biophysical Basis and Technical Approaches - Volume 1 (2014)

    Fulltext@MSK | Save
  • Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Schaer, D.; Yang, X.; Zhong, H.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Blockade of surface bound TGF-β abrogates Treg suppression of effector T cell function within the tumor microenvironment
    Meeting Abstract

    Budhu, S.; Schaer, D.; Li, Y.; Houghton, A.; Silverstein, S.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
    Meeting Abstract

    Page, D. B.; McArthur, H.; Dong, Z.; Wong, P.; Emerson, R.; Mu, Z.; Zhao, C.; Comstock, C.; Morris, E.; Comen, E.; more...
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorlyimmunogenic tumors
    Meeting Abstract

    Zamarin, D.; Holmgaard, R. B.; Plitt, T.; Allison, J.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Patterns of long-term survival following Ipilimumab (Ipi): The Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience
    Meeting Abstract

    Page, D. B.; Naidoo, J.; Momtaz, P.; Bogatch, K.; Kuk, D.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Postow, M.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)
    Meeting Abstract

    Hodi, F. S.; Ribas, A.; Daud, A.; Hamid, O.; Robert, C.; Kefford, R.; Hwu, W. J.; Gangadhar, T. C.; Joshua, A. M.; Hersey, P.; more...
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma
    Meeting Abstract

    Postow, M.; Manuel, M.; Wong, P.; Yuan, J.; Noel, M.; Courtier, A.; Pasqual, N.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save